Skip to content

A Single-Arm, Prospective Clinical Study Evaluating the Efficacy of Digital Therapeutics in Prehabilitation Exercise for Lung Cancer Patients Before Surgery

A Single-Arm, Prospective Clinical Study Evaluating the Efficacy of Digital Therapeutics in Prehabilitation Exercise for Lung Cancer Patients Before Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077582
Enrollment
Unknown
Registered
2023-11-13
Start date
2023-11-13
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Intervention Group:In addition to standard care, patients in this study will be managed using digital software. The software will guide patients to perform 4 weeks of motivational pulmonary rehabilita

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 50 and 75 years old; 2. Received high school (including secondary specialized schools) education or above; 3. Patients who are aware of their diagnosis and planning to undergo lung resection surgery; 4. Body mass index within normal range: 18.5=BMI=23.9; 5. Mild to moderate decrease in baseline lung function before surgery: 50%= FEV1%<65%; 6. Health literacy score (BHLS) =10, able to independently use smart devices to complete electronic questionnaires; 7. Clear consciousness, no communication or cognitive impairment, signed informed consent form;

Exclusion criteria

Exclusion criteria: 1. Preoperative ECOG performance status =1; 2. Longest diameter of lung nodule on CT =8cm; 3. Patients who have received neoadjuvant therapy before surgery; 4. Patients with history of thoracic surgery; 5. Evidence of continuous systemic corticosteroid use within 1 month before surgery; 6. Any unresolved toxicity greater than CTCAE grade 1 from previous treatment; 7. Patients unable to exercise due to physical disabilities from previous diseases or injury; 8. History of major diseases, including other malignancies within 5 years, angina, myocardial infarction, or stroke within 6 months; 9. Current severe or uncontrolled systematic diseases; 10. Other situations judged by researchers as unsuitable for inclusion;

Design outcomes

Primary

MeasureTime frame
Change in actual FEV1 value before and after 4 weeks of prehabilitation exercise ?FEV1 (L);

Secondary

MeasureTime frame
Changes in lung function before and after 4 weeks of prehabilitation exercise: including FVC , PEF, MVV, DLco, FEV1%;Change in actual FEV1 value at 1 month after surgery compared to baseline ?FEV1 (L);Incidence of postoperative pulmonary complications (PPCs) within 1 month after surgery;Pulse oximetry oxygen saturation (SaO2) on postoperative day 2;

Countries

China

Contacts

Public ContactJingsi Dong,

West China Hospital of Sichuan University

djs_8923390@163.com+86 189 8060 5267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026